Fundraising Fox

Solve Therapeutics, Inc.

Belmont, US · Founded 2021 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

LM
Langdon MillerExecutive Officer
DJ
David JohnsonExecutive Officer, Director
CD
Clayton D. KnoxExecutive Officer
PC
Peter ColabuonoDirector
AC
Alan ColowickDirector
JP
Jason PittsDirector

Investors · 1

B4 Capitalreported$10M – $50Mvia Robert Mittendorff · board

Reported raises · per SEC filings

Form D private placements
▶$48.2MraisedNov 2025 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel McHughDirector
  • Langdon MillerExecutive Officer
  • David JohnsonExecutive Officer, Director
  • Clayton D. KnoxExecutive Officer
  • Robert MittendorffDirector
  • Alan ColowickDirector
  • Jason PittsDirector
  • Peter ColabuonoDirector
Offering amount
$120.5M
Amount sold
$48.2M
First sale
Nov 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50.4MraisedDec 2024 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter ColabuonoDirector
  • Langdon MillerExecutive Officer
  • Alan ColowickDirector
  • David JohnsonExecutive Officer, Director
  • Clayton D. KnoxExecutive Officer
  • Jason PittsDirector
Offering amount
$75.6M
Amount sold
$50.4M
First sale
Dec 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$63.5MraisedJan 2022 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter ColabuonoDirector
  • Langdon MillerExecutive Officer
  • Alan ColowickDirector
  • David JohnsonExecutive Officer, Director
Offering amount
$126.5M
Amount sold
$63.5M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.